NL-OMON25436
Completed
Not Applicable
Randomized Trial of optimal conventional therapy versus optimal conventional therapy plus counterpressure manoeuvres in patients with neurally-mediated syncope.
ConditionsVasovagal syncope. <br />
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Vasovagal syncope. <br />
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
- J Am Coll Cardiol. 2006 Oct 17;48(8):1652-7. Epub 2006 Sep 26.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Clinical diagnosis of classical neurally\-mediated reflex syncope, based on the medical history ór non\-classical diagnosis of neurally\-mediated reflex syncope and a positive tilt\-table test.
Exclusion Criteria
- •1\. Suspected or certain heart disease and high likelihood of cardiac syncope:
- •a. Syncope preceded by palpitations or precordial pain;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Randomized Clinical Trial for Optimal Cardiac Rehabilitation.NL-OMON19956Radboud University Nijmegen Medical Centre210
Completed
Not Applicable
Randomized Clinical Trial for optimal Cardiac Rehabilitation: A traditional Dutch Cardiac Rehabilitation Program versus a Canadian High Efficiency Cardiac Rehabilitation Programcoronary syndromeheart attack10028593NL-OMON36989niversitair Medisch Centrum Sint Radboud210
Recruiting
Phase 1
Hypomemylating Agents Combination With eDC Therapy for Elderly Patients With Myelodysplastic SyndromeMyelodysplastic SyndromesDendritic CellHypomethylating AgentsImmunotherapyNCT04999943Affiliated Hospital to Academy of Military Medical Sciences40
Suspended
Not Applicable
A Randomized Clinical Trial of the Effectiveness of Ventilation by Oxylator EMX versus Bag-Valve Device in pre-hospital emergency patients.All emergency conditions that require mask ventilation.NL-OMON23375CPR Medical, Toronto Canada, www.cprmedic.com200
Completed
Phase 2
Treatment of cardiac amyloid light-chain amyloidosis with the green tea compound epigallocatechin-3-galiateAmyloid light-chain amyloidosisNutritional, Metabolic, EndocrineAmyloidosisISRCTN68399350Ruprecht-Karls-University of Heidelberg (Germany)38